Interventional Cardiology
and Angioplasty Program
Our Program includes a team of dedicated interventional
cardiologists, specially trained nurses, and technicians.
Together they provide the highest level of care
to patients with:
When you come to Penn Cardiac Care at Pennsylvania
Hospital, you benefit from our on-site digital
catheterization laboratories. Procedures available
include:
Drug-Eluting Stents
When a bare metal stent is implanted in a blocked
artery, there is a risk that the buildup of plaque
will recur around the stent several months after
implantation, a condition called restenosis. If
this happens, additional procedures may be required.
 Drug-eluting
stents are a dramatic technological advancement,
which have been proven to significantly reduce
the risk of restenosis among patients. These stents
are lined with medication which inhibit the build
up of plaque in the artery directly around the
stent, allowing blood to flow. Penn Cardiac Care
interventional cardiologists were among the few
in the country to help develop these stents and
participated in a study which evaluated their
effectiveness. While the risk of restenosis with
traditional stents is 20 percent, the study indicated
that drug-eluting stents decrease the risk to
just five percent, allowing patients to avoid
additional interventions and maintain their lifestyle.
Following the recent approval of drug-eluting
stents by the Food and Drug Administration, our
doctors are implanting them in most patients.
To learn if you are a candidate for this procedure,
please speak to your doctor.
Interventional Cardiogy
Vidya
S. Banka, MD, FACC
Jospeh
R. DeSantola, MD, FACC
Howard
L. Haber, MD, FACC
|
